Litcius/Paper detail

Risk of thromboembolism in patients with ALK‐ and EGFR‐mutant lung cancer: A cohort study

Joanna Roopkumar, Shyam K. Poudel, Lorenzo Gervaso, C.A. Reddy, Vamsidhar Velcheti, Nathan A. Pennell, Keith R. McCrae, Alok A. Khorana

2020Journal of Thrombosis and Haemostasis64 citationsDOI

Topics & Concepts

MedicineInternal medicineCumulative incidenceLung cancerOncologyHazard ratioProportional hazards modelPopulationEpidermal growth factor receptorCohortPulmonary embolismCancerAnaplastic lymphoma kinaseGastroenterologyConfidence intervalEnvironmental healthMalignant pleural effusionVenous Thromboembolism Diagnosis and ManagementCardiac tumors and thrombiInflammatory Biomarkers in Disease Prognosis
Risk of thromboembolism in patients with ALK‐ and EGFR‐mutant lung cancer: A cohort study | Litcius